Other inhibitors

Items 401-450 of 980

Page
per page
Set Descending Direction
Catalog No.
Product Name
Application
Product Information
Citations
  1. Carbazochrome sodium sulfonate (AC-17) is an antihemorrhagic for use in the treatment of hemorrhoids.
  2. Carbimazole is an imidazole antithyroid agent.
  3. Carzenide is an organic synthesis intermediate, used for synthetic drug.
  4. Chromocarb is a synthetic vasoprotectant.
  5. Cinchophen is an analgesic drug that is frequently used to treat gout.
  6. Citiolone is a derivative of the amino acid cysteine, used in liver therapy.
  7. Cysteamine is an agent for the treatment of nephropathic cystinosis and an antioxidant.
  8. Cytidine is a nucleoside molecule that is formed when cytosine is attached to a ribose ring, cytidine is a component of RNA.
  9. hydroxyl radical-specific scavenger

    Nicaraven is a novel chemically synthesized hydroxyl radical-specific scavenger.
  10. Stemness kinase inhibitor

    Amcasertib (BBI503), a first-in-class cancer stemness kinase inhibitor, is claimed to inhibit Nanog and other CSC pathways by targeting kinases with potential anticancer activity.
  11. meta-Topolin is an aromatic cytokinin, first isolated from leaves of Populus x robusta. Cytokinins (CTKs) are a class of growth-regulating hormones involved in various physiological and developmental processes.
  12. Rio2 kinase (RIOK2) inhibitor

    NSC139021 (ERGi-USU) is a highly selective inhibitor for the growth of ERG-positive cancer cells with IC50s ranging from 30 to 400 nM.
  13. Type-I Kinase Inhibitor

    VI-16832 is a broad spectrum type-I kinase inhibitor
  14. LOXL2 inhibitor

    LOXL2-IN-1 HCl is a selective LOXL2 inhibitor with an IC50 of 126 nM.
  15. Analgesic

    Nifenazone is a drug used as an analgesic for a number of rheumatic conditions.
  16. Nafocare B1 is a synthetic immune biological response modifier.
  17. NFTs tracer

    MK-6240 is a positron emission tomography (PET) tracer for neurofibrillary tangles (NFTs), exhibiting high specificity and selectivity for binding to NFTs.
  18. PET tracer

    T807 a novel tau positron emission tomography (PET) tracer.
  19. TN1

    HbF inducer

    TN1 is a potent fetal hemoglobin (HbF) inducer.
  20. Dansyl glutathione is a trapping agent for the quantitative estimation and identification of reactive metabolites.
  21. IGPS inhibitor

    ATB107 is a novel and potent inhibitor of indole-3-glycerol phosphate synthase (IGPS) with a KD of 3 μM.
  22. FOXM1 inhibitor

    RCM-1 is a FOXM1 inhibitor.
  23. breast cancer stem cells inhibitor

    ML239 is a potent and selective inhibitor of breast cancer stem cells, with an IC50 of 1.16 μM.
  24. nitrification inhibitor

    3-Methylpyrazole is used as a nitrification inhibitor of nitrification in soil.
  25. F 16915 is a docosahexaenoic acid derivative which can prevent heart failure-induced atrial fibrillation.
  26. p18 inhibitor

    NSC23005 sodium is a novel and effective p18 inhibitor (ED50=5.21 nM) in promoting Hematopoietic stem cells (HSCs) expansion in both murine and human models.
  27. BAL-30072, a siderophore sulfactam, is a monocyclic beta-lactam antibiotic, with activity against multiresistant gram-negative bacilli.
  28. PCA-1/ALKBH3 inhibitor

    HUHS015 is a potent PCA-1/ALKBH3 inhibitor both in vitro and in vivo.
  29. E-982 is extracted from the reference, compound 12.
  30. fibrinogen receptor antagonist

    SC-52012 is an orally active fibrinogen receptor antagonist, with antiplatelet activities.

  31. memory-enhancing agent

    CL-275838 is a memory-enhancing agent, also with potent antidepressant activities.
  32. PEP inhibitor

    Z-321 is a prolylendopeptidase (PEP) inhibitor.
  33. KW-6055 is a benzylpyridine derivative and has anti-amnesic activity.
  34. Trombodipine is an antithrombotic agent.
  35. hypolipidemic agent

    TA-1801 is a hypolipidemic agent.
  36. Fenclozine is a non-steroidal antiinflammatory drug extracted from patent WO 2012112690 A2.
  37. Valrocemide (TV1901) is a promising antiepileptic drug candidate that shows a broad spectrum of anticonvulsant activity.
  38. FKK

    bronchodilator

    FKK is an indazole derivative and also a novel bronchodilator.
  39. glycogen phosphorylase inhibitor

    Ingliforib is a glycogen phosphorylase inhibitor, with IC50s of 52, 352 and 150 nM for liver, muscle and brain glycogen phosphorylase, and has cardioprotective activity.
  40. Cease inhibitor

    SMP-028 is an inhibitor of neutral cholesterol esterase (CEase), with an IC50 of 1.01 μM.
  41. LS2265 is a taurine derivative of fenofibrate and can induce proliferation of peroxisomes in liver cells of rats.
  42. hTGase inhibitor

    LDN-27219 is a potent inhibitor of hTGase(Tissue transglutaminase) with an IC50 of 0.6 uM.
  43. squalene synthase inhibitor

    Lapaquistat acetate (TAK-475) is a squalene synthase inhibitor, blocking the conversion of farnesyl diphosphate (FPP) to squalene.
  44. HbS polymerization inhibitor

    Voxelotor (GBT 440) is an orally bioavailable sickle hemoglobin (HbS) polymerization inhibitor.
  45. α-Tocopherol phosphate is the compound demonstrating the highest vitamin E activity, which is available both in its natural form as RRR-alpha-tocopherol isolated from plant sources.
  46. Glufosfamide is a novel alkylating agent in which the active metabolite of isophosphoramide mustard is glycosidically linked to β-D-glucose.
  47. PROTO-1 shows significant protection of hair cells, with HC50(concentration that would produce 50% hair cell survival) of 1 μM-10 μM (1 μM??HC50??10 μM).
  48. BoNTA LC inhibitor

    BoNT-IN-1 is a potent inhibitor of Botulinum neurotoxin A light chain (BoNTA LC) with IC50 of 0.9 uM.
  49. metal chelators

    HQ-415 is a class of clinically relevant bioactive metal chelators related to clioquinol. The effective concentration eliciting a EC50 for HQ-415 is 15 μM.
  50. SAHH inhibitor

    DZ2002 is a potent and reversible S-Adenosyl-L-homocysteine Hydrolase(SAHH; AdoHcy Hydrolase) inhibitor with Ki of 17.9 nM.

Items 401-450 of 980

Page
per page
Set Descending Direction